Marex Group (MRX) Investor Day 2025 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 summary
8 Jul, 2026Strategic Direction and Business Performance
Maintained a consistent strategy since IPO, focusing on scalable, diversified growth through organic initiatives and selective, value-accretive acquisitions, with a 60/40 organic/inorganic mix over time.
Outperformed competitors with 28% revenue growth to $1.6bn and 40% profit growth to $321m in 2024, supported by both organic expansion and successful M&A.
Achieved a 10-year track record of 20% revenue CAGR and 35% profit CAGR, placing the firm in the top 0.1% of public companies for growth.
Enhanced brand recognition and public company status have improved client acquisition, talent recruitment, and M&A opportunities, with a strong position as a top-10 FCM in the US.
Targeting 10–20% annual growth and mid-20% margin expansion over the next five years, aiming for $500–$800 million profit by 2029.
Business Segments and Growth Drivers
Clearing is central, representing 53% of operating profits, with $13 billion in client balances, 1.1bn contracts cleared in 2024, and top-10 FCM status in the US.
Agency & Execution is the largest revenue segment, generating $700 million, with 55% CAGR over three years and margin improvement to 19%.
Market Making delivered $200 million revenue at 35% margin, with 98% positive P&L weeks and a diversified, low-risk model across 39 asset classes.
Solutions business (custom derivatives) grew to $162 million revenue at 26% margin, with strong demand for customized derivatives and structured products.
Growth is driven by adding clients, cross-selling, expanding product range, and entering new geographies, especially the U.S., Middle East, and APAC.
Financials, Capital, and Risk Management
Revenues reached $1.6 billion in 2024, with adjusted profits of $321 million, ROE of 25–30%, and margin expansion to 20%.
Net interest income contributed 14% of revenues, with limited rate sensitivity due to a balanced mix of client-shared and retained balances.
Maintains strong capital and liquidity, with $1 billion surplus funding, low leverage, investment-grade ratings, and a 234% total capital ratio in 2024.
Disciplined M&A approach, targeting 4–5 bolt-on deals per year, with strict margin and ROE criteria and proven post-acquisition integration.
Robust risk management culture, low credit losses, two-thirds of credit exposure collateralized, and strong operational resilience underpin stable profitability.
Latest events from Marex Group
- Record Q1 2026 revenue and profit growth reflect a resilient, diversified, and scalable platform.MRX
Investor presentation8 Jul 2026 - Double-digit growth and infrastructure-led businesses drive record earnings and resilience.MRX
Investor Day 20268 Jul 2026 - Record profit growth, expanding margins, and strategic M&A drive robust, resilient performance.MRX
Piper Sandler Global Exchange and Fintech Conference3 Jun 2026 - All resolutions, including Bermuda redomiciliation, passed to streamline structure and support growth.MRX
EGM 20263 Jun 2026 - 2025 saw 27% revenue growth, 30% profit growth, and expanding margins from scalable, recurring earnings.MRX
Investor presentation18 May 2026 - Record Q1 2026 revenue and profit growth driven by strong segment performance and market volatility.MRX
Q1 20266 May 2026 - Record FY 2025 profit and revenue growth, supported by scale, diversification, and strong risk controls.MRX
Corporate presentation24 Mar 2026 - Record revenue and profit growth in 2025, with strong segment performance and robust capital position.MRX
Q4 20253 Mar 2026 - Record H1 2024 results with 27% revenue growth, strong margins, and positive full-year outlook.MRX
H1 20242 Feb 2026